Northern Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91M | Sell |
1,655,111
-41,753
| -2% | -$2.3M | 0.01% | 754 |
|
|
2025
Q1 | $120M | Sell |
1,696,864
-28,175
| -2% | -$1.99M | 0.02% | 643 |
|
|
2024
Q4 | $113M | Buy |
1,725,039
+240,681
| +16% | +$15.8M | 0.02% | 662 |
|
|
2024
Q3 | $104M | Sell |
1,484,358
-93,901
| -6% | -$6.6M | 0.02% | 630 |
|
|
2024
Q2 | $130M | Buy |
1,578,259
+500,230
| +46% | +$41.2M | 0.02% | 535 |
|
|
2024
Q1 | $94.2M | Sell |
1,078,029
-72,754
| -6% | -$6.35M | 0.02% | 655 |
|
|
2023
Q4 | $111M | Sell |
1,150,783
-69,031
| -6% | -$6.66M | 0.02% | 588 |
|
|
2023
Q3 | $108M | Buy |
1,219,814
+43,695
| +4% | +$3.87M | 0.02% | 568 |
|
|
2023
Q2 | $102M | Sell |
1,176,119
-129,319
| -10% | -$11.2M | 0.02% | 588 |
|
|
2023
Q1 | $127M | Buy |
1,305,438
+248
| +0% | +$24.1K | 0.03% | 527 |
|
|
2022
Q4 | $135M | Buy |
1,305,190
+11,683
| +0.9% | +$1.21M | 0.03% | 500 |
|
|
2022
Q3 | $110M | Sell |
1,293,507
-11,020
| -0.8% | -$934K | 0.03% | 514 |
|
|
2022
Q2 | $108M | Sell |
1,304,527
-21,927
| -2% | -$1.82M | 0.02% | 542 |
|
|
2022
Q1 | $102M | Sell |
1,326,454
-37,047
| -3% | -$2.86M | 0.02% | 636 |
|
|
2021
Q4 | $120M | Buy |
1,363,501
+8,188
| +0.6% | +$723K | 0.02% | 607 |
|
|
2021
Q3 | $105M | Buy |
1,355,313
+70,868
| +6% | +$5.48M | 0.02% | 638 |
|
|
2021
Q2 | $107M | Buy |
1,284,445
+69,449
| +6% | +$5.79M | 0.02% | 645 |
|
|
2021
Q1 | $91.7M | Buy |
1,214,996
+30,432
| +3% | +$2.3M | 0.02% | 713 |
|
|
2020
Q4 | $104M | Sell |
1,184,564
-36,355
| -3% | -$3.19M | 0.02% | 627 |
|
|
2020
Q3 | $92.9M | Sell |
1,220,919
-73,890
| -6% | -$5.62M | 0.02% | 592 |
|
|
2020
Q2 | $160M | Buy |
1,294,809
+72,606
| +6% | +$8.96M | 0.04% | 404 |
|
|
2020
Q1 | $103M | Buy |
1,222,203
+83,344
| +7% | +$7.04M | 0.03% | 462 |
|
|
2019
Q4 | $96.3M | Sell |
1,138,859
-53,379
| -4% | -$4.51M | 0.02% | 604 |
|
|
2019
Q3 | $80.4M | Sell |
1,192,238
-24,025
| -2% | -$1.62M | 0.02% | 656 |
|
|
2019
Q2 | $104M | Buy |
1,216,263
+13,949
| +1% | +$1.19M | 0.02% | 563 |
|
|
2019
Q1 | $107M | Buy |
1,202,314
+20,108
| +2% | +$1.79M | 0.03% | 534 |
|
|
2018
Q4 | $101M | Buy |
1,182,206
+75,550
| +7% | +$6.43M | 0.03% | 515 |
|
|
2018
Q3 | $107M | Sell |
1,106,656
-2,407
| -0.2% | -$233K | 0.03% | 530 |
|
|
2018
Q2 | $104M | Buy |
1,109,063
+12,326
| +1% | +$1.16M | 0.03% | 540 |
|
|
2018
Q1 | $88.9M | Sell |
1,096,737
-13,295
| -1% | -$1.08M | 0.02% | 607 |
|
|
2017
Q4 | $99M | Buy |
1,110,032
+5,952
| +0.5% | +$531K | 0.03% | 571 |
|
|
2017
Q3 | $103M | Buy |
1,104,080
+6,509
| +0.6% | +$606K | 0.03% | 540 |
|
|
2017
Q2 | $99.7M | Buy |
1,097,571
+31,113
| +3% | +$2.83M | 0.03% | 529 |
|
|
2017
Q1 | $93.6M | Buy |
1,066,458
+26,940
| +3% | +$2.36M | 0.03% | 553 |
|
|
2016
Q4 | $86.1M | Sell |
1,039,518
-254,800
| -20% | -$21.1M | 0.03% | 559 |
|
|
2016
Q3 | $120M | Buy |
1,294,318
+83,584
| +7% | +$7.73M | 0.04% | 439 |
|
|
2016
Q2 | $94.2M | Buy |
1,210,734
+44,857
| +4% | +$3.49M | 0.03% | 514 |
|
|
2016
Q1 | $103M | Buy |
1,165,877
+31,645
| +3% | +$2.8M | 0.03% | 470 |
|
|
2015
Q4 | $119M | Sell |
1,134,232
-70,385
| -6% | -$7.37M | 0.04% | 420 |
|
|
2015
Q3 | $127M | Sell |
1,204,617
-73,119
| -6% | -$7.7M | 0.04% | 408 |
|
|
2015
Q2 | $175M | Sell |
1,277,736
-55,657
| -4% | -$7.61M | 0.05% | 339 |
|
|
2015
Q1 | $166M | Buy |
1,333,393
+33,852
| +3% | +$4.22M | 0.05% | 355 |
|
|
2014
Q4 | $117M | Buy |
1,299,541
+43,797
| +3% | +$3.96M | 0.04% | 450 |
|
|
2014
Q3 | $90.6M | Buy |
1,255,744
+235,662
| +23% | +$17M | 0.03% | 512 |
|
|
2014
Q2 | $63.5M | Sell |
1,020,082
-430,486
| -30% | -$26.8M | 0.02% | 660 |
|
|
2014
Q1 | $98.9M | Buy |
1,450,568
+259,007
| +22% | +$17.7M | 0.03% | 494 |
|
|
2013
Q4 | $83.8M | Buy |
1,191,561
+71,015
| +6% | +$5M | 0.03% | 518 |
|
|
2013
Q3 | $80.9M | Buy |
1,120,546
+5,316
| +0.5% | +$384K | 0.03% | 498 |
|
|
2013
Q2 | $62.2M | Buy |
+1,115,230
| New | +$62.2M | 0.02% | 565 |
|